Woman and Man
- | Country : -
- | organs : -
- | Specialty : -
Extract
To determine the percent reduction in the rate of febrile reactions when prophylactic antipyretic treatment is administered relative to no prophylactic antipyretic treatment after vaccination with a 7-valent pneumococcal conjugate vaccine (7vPnC, Prevenar®) and routine DTPa-HBV-IPV+Hib (Infanrix hexa®) vaccination at 2, 3, 4 (primary series) and 11-14 (booster dose) months of age.
Inclusion criteria
- Healthy infants who shall receive their first routine vaccination